Literature DB >> 8612607

Purification and characterization of human topoisomerase I mutants.

A D Jensen1, J Q Svejstrup.   

Abstract

A system for rapid purification and characterization of eukaryotic topoisomerase-I mutants has been developed. The system utilizes six-histidine tagging of human topoisomerase I expressed in Saccharomyces cerevisiae to enable purification by nickel-affinity chromatography. Virtually homogenous mutant proteins are then tested for their ability to relax supercoiled DNA plasmids and their capacity for binding, cleaving and religating short defined DNA substrates. Relaxation-deficient mutants were obtained by site-directed mutagenesis of selected highly conserved amino acids. The mutants Tyr723Phe (active site mutation), Arg488Gln and Lys532Glu were inert in relaxation of DNA, whereas Lys720Glu showed a 50-fold reduction in specific relaxation activity. Accordingly, only Lys720Glu showed low, but detectable cleavage activity on suicide DNA substrates, uncoupling the cleavage and religation events of topoisomerase I. The relative religation efficiency of Lys720Glu comparable to that of wild-type topoisomerase I, indicating that Lys720 is involved in interactions important for normal DNA cleavage, but not for the religation reaction. All mutants could be cross linked by ultraviolet light to bromo-dUTP-substituted DNA oligonucleotides carrying a topoisomerase-I-binding site, indicating that the deficiency of Tyr723Phe, Arg488Gln and Lys532Glu in DNA relaxation and cleavage is not due to an inability of these mutants to bind DNA non-covalently.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612607     DOI: 10.1111/j.1432-1033.1996.00389.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.

Authors:  J Wittschieben; S Shuman
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

2.  Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state.

Authors:  Vijay K Tiwari; Lukas Burger; Vassiliki Nikoletopoulou; Ruben Deogracias; Sudhir Thakurela; Christiane Wirbelauer; Johannes Kaut; Remi Terranova; Leslie Hoerner; Christian Mielke; Fritz Boege; Rabih Murr; Antoine H F M Peters; Yves-Alain Barde; Dirk Schübeler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 3.  DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.

Authors:  Carlos García-Estrada; Christopher Fernández Prada; Celia Fernández-Rubio; Francisco Rojo-Vázquez; Rafael Balaña-Fouce
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

4.  The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity.

Authors:  F Rossi; E Labourier; I E Gallouzi; J Derancourt; E Allemand; G Divita; J Tazi
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

5.  Functional expression of a DNA-topoisomerase IB from Cryptosporidium parvum.

Authors:  César Ordóñez; Javier Alfonso; Rafael Balaña-Fouce; David Ordóñez
Journal:  J Biomed Biotechnol       Date:  2009-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.